Level of hesitancy towards the COVID-19 vaccine in a marginal urban area of Lima
Nivel de vacilación frente a la vacuna contra COVID-19 en una zona urbano marginal de Lima
DOI:
https://doi.org/10.22258/hgh.2022.61.112Abstract
Objective: To determine the frequency and the factors associated with the refusal of vaccination against COVID-19 in the marginal urban area of Lima. Materials and methods: Quantitative, observational and descriptive cross-sectional study carried out in the year 2021. The population was made up of residents of the "Nueva Juventud" Human Settlement located in the district of Carabayllo, in the North of Lima. The study variable was the refusal of vaccination against COVID-19. Results: 405 people of both sexes participated with a median age of 30 years (Q1: 23, Q3: 42, Interquartile range: 19). Of the sample, 47.9% (n=194) were between 18 and 29 years old, 62% (n=251) corresponding to the female sex, most of the participants had a higher education degree and were users of the Comprehensive Health Insurance (SIS). 64% (n=259) reported a history of COVID-19. Regarding the level of hesitation, in 21.5% (n=87) it was low, 48.6% (n=197) moderate and 29.9% (n=121) presented a high level of hesitation. The high level of hesitation occurred in a greater proportion in older residents (p<0.001) and people with a lower level of education (p=0.001). The lowest percentage of high hesitation was presented in users of the SIS (p=0.005). Conclusions: There is a predominance of moderate and high level of hesitation against the COVID-19 vaccine. High hesitation was greater in older people and in those with a lower level of education. It is recommended to improve communication strategies regarding the benefits of the COVID-19 vaccine. Keywords: Vaccination Refusal; COVID-19; COVID-19 Vaccines; Peru (Source: MeSH, NLM).Downloads
References
World Health Organization. Weekly epidemiological update on COVID-19 - 14 September 2021 [Internet]. 2021 [citado 11 de mayo de 2022]. Disponible en: https://www.who.int/publications/m/item/weekly-epidemiological-update-on-covid-19---14-september-2021
Fantin R, Brenes-Camacho G, Barboza-Solís C. Defunciones por COVID-19: distribución por edad y universalidad de la cobertura médica en 22 países. Rev Panam Salud Pública. 28 de abril de 2021;45:1. Disponible en: https://doi.org/10.26633/RPSP.2021.42
Acosta LD. Capacidad de respuesta frente a la pandemia de COVID-19 en América Latina y el Caribe. Rev Panam Salud Pública. 16 de septiembre de 2020;44:1. Disponible en: doi: 10.26633/RPSP.2020.109
Centro Nacional de Epidemiología, Prevención y Control de Enfermedades. Situación Actual COVID 19 Perú 2020-2021: 12 de abril [Internet]. MINSA; 12 abril [citado 12 de noviembre de 2021]. Disponible en: http://bvs.minsa.gob.pe/local/covid/sala-situacional/coronavirus120421.pdf
Llover MN, Jiménez MC. Estado actual de los tratamientos para la COVID-19. FMC - Form Médica Contin En Aten Primaria. 1 de enero de 2021;28(1):40-56. Disponible en: doi: 10.1016/j.fmc.2020.10.005
Organización Mundial de la Salud. Brote de enfermedad por coronavirus (COVID-19): Orientaciones para el público [Internet]. 2020 [citado 12 de noviembre de 2021]. Disponible en: https://www.who.int/es/emergencies/diseases/novel-coronavirus-2019/advice-for-public
Ministerio de Salud. Proceso de vacunación contra el coronavirus [Internet]. MINSA. 2021 [citado 12 de noviembre de 2021]. Disponible en: https://www.gob.pe/13328-proceso-de-vacunacion-contra-el-coronavirus
Lazarus JV, Ratzan SC, Palayew A, Gostin LO, Larson HJ, Rabin K, et al. A global survey of potential acceptance of a COVID-19 vaccine. Nat Med. febrero de 2021;27(2):225-8.
Reiter PL, Pennell ML, Katz ML. Acceptability of a COVID-19 vaccine among adults in the United States: How many people would get vaccinated? Vaccine. 29 de septiembre de 2020;38(42):6500-7. Disponible en: doi: 10.1016/j.vaccine.2020.08.043
Khubchandani J, Sharma S, Price JH, Wiblishauser MJ, Sharma M, Webb FJ. COVID-19 Vaccination Hesitancy in the United States: A Rapid National Assessment. J Community Health. 1 de abril de 2021;46(2):270-7. Disponible en: doi: 10.1007/s10900-020-00958-x
Yigit M, Ozkaya-Parlakay A, Senel E. Evaluation of COVID-19 Vaccine Refusal in Parents. Pediatr Infect Dis J. abril de 2021;40(4):e134-6. Disponible en: doi: 10.1097/INF.0000000000003042
Dubé E, Gagnon D, Nickels E, Jeram S, Schuster M. Mapping vaccine hesitancy—Country-specific characteristics of a global phenomenon. Vaccine. 20 de noviembre de 2014;32(49):6649-54. Disponible en: 10.1016/j.vaccine.2014.09.039
Bernal Vaquera BM, Morales Jinez A, Moreno Perez NE. Indecisión a las vacunas: una revisión sistemática para abordar el fenómeno en Latinoamérica | SANUS. SANUS. 20 de julio de 2021;6(1):e182. Disponible en: https://doi.org/10.36789/sanus.vi1.182
World Health Organization. Report of the SAGE working group on vaccine hesitancy [Internet]. United Stated: World Health Organization. 2014 [citado 12 de noviembre de 2021]. Disponible en: https://cdn.who.int/media/docs/default-source/immunization/sage/2014/october/sage-working-group-revised-report-vaccine-hesitancy.pdf?sfvrsn=240a7c1c_4
Rodriguez VJ, Alcaide ML, Salazar AS, Montgomerie EK, Maddalon MJ, Jones DL. Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV. AIDS Behav. 1 de enero de 2022;26(1):96-101. Disponible en: doi: 10.1007/s10461-021-03350-5
Cheney MK, John R. Underutilization of Influenza Vaccine: A Test of the Health Belief Model. SAGE Open. 1 de abril de 2013;3(2):215824401348473. Disponible en: https://doi.org/10.1177/2158244013484732
Herrera-Añazco P, Uyen-Cateriano Á, Urrunaga-Pastor D, Bendezu-Quispe G, Toro-Huamanchumo CJ, Rodríguez-Morales AJ, et al. Prevalencia y factores asociados a la intención de vacunarse contra la COVID-19 en el Perú. Rev Peru Med Exp Salud Publica. julio de 2021;38(3):381-90. Disponible en: doi: https://doi.org/10.17843/rpmesp.2021.383.7446
Caycho-Rodríguez T, Carbajal-León C, Vivanco-Vidal A, Saroli-Araníbar D. Intención de vacunarse contra la COVID-19 en adultos mayores peruanos. Rev Esp Geriatría Gerontol. julio de 2021;56(4):245-6. Disponible en: doi: 10.1016/j.regg.2021.03.005
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Guerra-Pizango Lucia, Cereceda-Pinares Ruth, Flores-Acosta Noemi, Zamora-Villalobos Segundo, Roque-Utrilla Estefanny
This work is licensed under a Creative Commons Attribution 4.0 International License.
Authors who publish with this journal agree to the following terms:
- The authors will retain their copyright and will guarantee to the journal right of first publication of their work, which will simultaneously be under a Creative Commons Attribution 4.0 License that allows third parties to share the work whenever attribuying their author and first publication in this journal.
- The Author is able to enter into separate, additional contractual arrangements for the nonexclusive distribution of the journal's published version of the Work (e.g., post it to an institutional repository or publish it in a book), as long as there is provided in the document an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post online a pre-publication manuscript (but not the Publisher’s final formatted PDF version of the Work) in institutional repositories or on their Websites prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (see The Effect of Open Access).
![](<p><img src="https://www.redib.org/themes/lotura/images/logo.svg" alt="REDIB" /></p>){kind=logo}
![REDIB](<p><img%20src="https://www.redib.org/themes/lotura/images/logo.svg" alt="REDIB" /></p>){kind=logo}
![Ciencia Nueva hará parte del índice de Revistas en Consolidación de América Latina AmeliCA - Gestión de la Comunicación y la Promoción Institucional](<p><img%20src="https://comunicaciones.utp.edu.co/wp-content/uploads/sites/2/Melica-21-de-sep-2021.jpg" alt="Ciencia Nueva hará parte del índice de Revistas en Consolidación de América Latina AmeliCA - Gestión de la Comunicación y la Promoción Institucional" /></p>)
